Scarica l'app Stockscreener
0.806
1.66%
0.0132
Dopo l'orario di chiusura:
.83
0.024
+2.98%
Precedente Chiudi:
$0.7928
Aprire:
$0.79
Volume 24 ore:
88,400
Relative Volume:
0.39
Capitalizzazione di mercato:
$62.80M
Reddito:
$8.23M
Utile/perdita netta:
$-32.49M
Rapporto P/E:
-1.5208
EPS:
-0.53
Flusso di cassa netto:
$-19.91M
1 W Prestazione:
-4.05%
1M Prestazione:
+8.93%
6M Prestazione:
-15.60%
1 anno Prestazione:
-34.47%
Intervallo 1D:
$0.785
$0.83
Intervallo di 1 settimana:
$0.77
$0.84
Portata 52W:
$0.7001
$1.65
Clearside Biomedical Inc Stock (CLSD) Company Profile
Nome
Clearside Biomedical Inc
Settore
Industria
Telefono
678-270-3631
Indirizzo
900 NORTH POINT PARKWAY, ALPHARETTA, GA
Confronta CLSD con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CLSD
Clearside Biomedical Inc
|
0.806 | 62.80M | 8.23M | -32.49M | -19.91M | -0.53 |
|
VRTX
Vertex Pharmaceuticals Inc
|
457.03 | 115.95B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
547.74 | 56.52B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
329.77 | 39.44B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
545.11 | 35.14B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
244.32 | 28.51B | 3.81B | -644.79M | -669.77M | -6.24 |
Clearside Biomedical Inc Stock (CLSD) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-08-21 | Iniziato | Chardan Capital Markets | Buy |
| 2024-06-25 | Iniziato | Oppenheimer | Outperform |
| 2021-12-15 | Ripresa | Wedbush | Outperform |
| 2021-07-29 | Iniziato | H.C. Wainwright | Buy |
| 2020-05-13 | Iniziato | ROTH Capital | Buy |
| 2019-08-09 | Downgrade | Needham | Buy → Hold |
| 2018-11-05 | Downgrade | Cowen | Outperform → Market Perform |
| 2018-11-05 | Downgrade | JP Morgan | Overweight → Underweight |
| 2018-11-05 | Downgrade | Stifel | Buy → Hold |
| 2018-03-06 | Reiterato | Needham | Buy |
| 2017-05-25 | Iniziato | JMP Securities | Mkt Outperform |
| 2017-02-24 | Iniziato | JP Morgan | Overweight |
| 2016-11-10 | Reiterato | Needham | Buy |
| 2016-10-24 | Reiterato | Stifel | Buy |
Mostra tutto
Clearside Biomedical Inc Borsa (CLSD) Ultime notizie
Clearside Biomedical Announces Multiple Presentations to be Featured at the Clinical Trials at the Summit Meeting - GlobeNewswire
Clearside Biomedical Announces Multiple Presentations to be Feat - GuruFocus
Clearside Biomedical Announces Multiple Presentations to be Featured at the Clinical Trials at the Summit Meeting | CLSD Stock News - GuruFocus
Clearside Biomedical Showcases Suprachoroidal Injection Platform for Retinal Diseases at CTS Meeting - Nasdaq
Comprehensive Age-related Macular Degeneration Market Analysis: Trends and Developments Across All Types - GlobeNewswire Inc.
Clearside Biomedical, Inc. (NASDAQ:CLSD) Given Consensus Recommendation of “Buy” by Brokerages - Defense World
Northern Trust Corp Has $157,000 Holdings in Clearside Biomedical, Inc. (NASDAQ:CLSD) - Defense World
Clearside Biomedical Approves Share Increase at Annual Meeting - TipRanks
Clearside Biomedical (CLSD) Upgraded to Buy: Here's What You Should Know - MSN
Clearside Biomedical (CLSD) Gets a Buy from H.C. Wainwright - The Globe and Mail
Clearside Biomedical’s SWOT analysis: eye disease stock faces funding hurdles amid promising pipeline - Investing.com India
Clearside Biomedical target cut to $5 by H.C. Wainwright - Investing.com
HC Wainwright Lowers Clearside Biomedical (NASDAQ:CLSD) Price Target to $5.00 - Defense World
Clearside Biomedical (CLSD) Price Target Lowered by Analyst | CL - GuruFocus
H.C. Wainwright Adjusts Price Target for Clearside Biomedical (C - GuruFocus
Clearside Biomedical (CLSD) Price Target Lowered by Analyst | CLSD Stock News - GuruFocus
Clearside Biomedical to Participate in a Fireside Chat at the St - GuruFocus
Clearside Biomedical to Participate in a Fireside Chat at the Stifel 2025 Virtual Ophthalmology Forum | CLSD Stock News - GuruFocus
Clearside Biomedical to Participate in a Fireside Chat at the Stifel 2025 Virtual Ophthalmology Forum - GlobeNewswire
Clearside Biomedical Reveals Next-Gen Eye Therapy Platform at Exclusive Stifel Conference - Stock Titan
Analysts Set Clearside Biomedical, Inc. (NASDAQ:CLSD) Price Target at $5.00 - Defense World
JMP Securities Reiterates “Market Outperform” Rating for Clearside Biomedical (NASDAQ:CLSD) - Defense World
Clearside Biomedical (NASDAQ:CLSD) Raised to Hold at StockNews.com - Defense World
Needham & Company LLC Lowers Clearside Biomedical (NASDAQ:CLSD) Price Target to $3.00 - Defense World
JMP maintains $5 target on Clearside Biomedical stock By Investing.com - Investing.com Nigeria
Clearside Biomedical (CLSD) Reiterates Market Outperform Rating - GuruFocus
Clearside Biomedical Reports Q1 2025 Financial Progress - TipRanks
Clearside Biomedical (CLSD) Target Price Lowered by Needham | CL - GuruFocus
Clearside Biomedical, Inc. (CLSD) Reports Q1 Loss, Tops Revenue Estimates - MSN
Stifel maintains Buy on Clearside Biomedical, target at $8 By Investing.com - Investing.com South Africa
Stifel maintains Buy on Clearside Biomedical, target at $8 - Investing.com Australia
Clearside Biomedical Inc (CLSD) Q1 2025 Earnings: EPS Matches Es - GuruFocus
Clearside (CLSD) Reports Strong Q1 Revenue Boost | CLSD Stock Ne - GuruFocus
Clearside Biomedical Inc (CLSD) Q1 2025 Earnings: EPS Matches Estimates at -$0.11, Revenue Surges to $2.3 Million, Exceeding Expectations - GuruFocus
Clearside Biomedical Inc reports results for the quarter ended March 31Earnings Summary - TradingView
CLEARSIDE BIOMEDICAL Earnings Results: $CLSD Reports Quarterly Earnings - Nasdaq
Clearside Biomedical Announces First Quarter 2025 Financial Results and Provides Corporate Update - GlobeNewswire
Clearside (CLSD) Reports Strong Q1 Revenue Boost | CLSD Stock News - GuruFocus
Clearside's Wet AMD Drug Advances to Phase 3: FDA Green Light Could Transform Eye Disease Treatment - Stock Titan
Clearside Biomedical Inc (CLSD) Q1 2025 Earnings Report Preview: What To Expect - GuruFocus
Clearside Biomedical (NASDAQ:CLSD) Cut to “Sell” at StockNews.com - Defense World
Investor Network: Clearside Biomedical, Inc. to Host Earnings Call - ACCESS Newswire
Clearside Biomedical Inc Azioni (CLSD) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Clearside Biomedical Inc Azioni (CLSD) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Chong Ngai Hang Victor | Chief Medical Officer |
Nov 01 '24 |
Buy |
1.00 |
36,500 |
36,500 |
100,000 |
1.45%
0.86%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):